Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01KMR
|
||||
Former ID |
DCL000895
|
||||
Drug Name |
Neramexane
|
||||
Synonyms |
Neramexane [INN]; Mrz 2579; MRZ 2-579; 1,3,3,5,5-Pentamethylcyclohexanamine; 1,3,3,5,5-pentamethylcyclohexan-1-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer pain [ICD9: 140-229, 338,780; ICD10:R52, G89] | Phase 2 | [536058] | ||
Therapeutic Class |
Analgesics
|
||||
Company |
Merz Pharmaceuticals GmbH
|
||||
Structure |
Download2D MOL |
||||
Formula |
C11H23N
|
||||
Canonical SMILES |
CC1(CC(CC(C1)(C)N)(C)C)C
|
||||
InChI |
1S/C11H23N/c1-9(2)6-10(3,4)8-11(5,12)7-9/h6-8,12H2,1-5H3
|
||||
InChIKey |
OGZQTTHDGQBLBT-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 219810-59-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | NMDA receptor | Target Info | Antagonist | [536058] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.